Janux Therapeutics JANX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Janux Therapeutics's operating lease liabilities (current)?
- Janux Therapeutics (JANX) reported operating lease liabilities (current) of $2.47M in Q1 2026.
- How has Janux Therapeutics's operating lease liabilities (current) changed year-over-year?
- Janux Therapeutics's operating lease liabilities (current) increased by 36.5% year-over-year, from $1.81M to $2.47M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.